Amgen (AMGN) Revenue — Quarter Ended Jun 30, 2025
Revenue increased during the quarter. This marks the highest quarterly figure in the trailing period.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q2
Revenue increased during the quarter. This marks the highest quarterly figure in the trailing period.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$9.2B
Revenue reported for this quarter.
Quarter-over-quarter
+12.6%
Change from the immediately preceding quarter.
Year-over-year
+9.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$34.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $8.5B | +23.2% |
| Dec 31, 2024 | $9.1B | +10.9% |
| Mar 31, 2025 | $8.1B | +9.4% |
| Jun 30, 2025 | $9.2B | +9.4% |
Revenue performance
The reported revenue rose compared with the prior quarter and the same quarter a year earlier. Both sequential and year-over-year comps showed positive movement.
Quarterly comparison
Sequentially, revenue improved from the immediately preceding quarter. On a year-over-year basis, revenue also increased compared with the same quarter one year earlier.
What to watch
Absent specific management commentary on drivers, the sustainability of this growth trajectory remains unconfirmed by qualitative context.